Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1981 May;13(5):957–962. doi: 10.1128/jcm.13.5.957-962.1981

Comparison of fluorescent-antibody, neutralizing-antibody, and complement-enhanced neutralizing-antibody assays for detection of serum antibody to respiratory syncytial virus.

T N Kaul, R C Welliver, P L Ogra
PMCID: PMC273923  PMID: 7016915

Abstract

A comparison of three assays for the detection of serum antibody to respiratory syncytial virus (RSV) was carried out on 47 serum samples obtained sequentially from infants and young children with RSV infection. Neutralizing-antibody (NA) activity was determined by a semimicromethod of plaque reduction. Complement-enhanced NA activity was determined by the addition of guinea pig complement to NA assays. RSV antibody responses in immunoglobulin G, immunoglobulin M, and immunoglobulin A classes were determined by using indirect immunofluorescence techniques for fluorescent-antibody (FAb) assay. Antibody to RSV was detectable by all three techniques as early as 4 days after the onset of illness. At all phases of illness, titers obtained by complement-enhanced NA assays were significantly greater than those obtained by NA or FAb assays (P less than 0.01). RSV-FAb titers determined in the immunoglobulin G class correlated well with those determined by complement-enhanced NA or NA assays. The data suggest that the FAb assay for detection of RSV antibody in serum is somewhat less sensitive but also less laborious and more rapid than NA assays.

Full text

PDF
957

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baughman R. H., Fenters J. D., Marquis G. S., Jr, Holper J. C. Effect of complement and viral filtration on the neutralization of respiratory syncytial virus. Appl Microbiol. 1968 Jul;16(7):1076–1080. doi: 10.1128/am.16.7.1076-1080.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Buynak E. B., Weibel R. E., Carlson A. J., McLean A. A., Hilleman M. R. Further investigations of live respiratory syncytial virus vaccine administered parenterally. Proc Soc Exp Biol Med. 1979 Feb;160(2):272–277. doi: 10.3181/00379727-160-40433. [DOI] [PubMed] [Google Scholar]
  3. CHANOCK R. M., KIM H. W., VARGOSKO A. J., DELEVA A., JOHNSON K. M., CUMMING C., PARROTT R. H. Respiratory syncytial virus. I. Virus recovery and other observations during 1960 outbreak of bronchiolitis, pneumonia, and minor respiratory diseases in children. JAMA. 1961 May 27;176:647–653. [PubMed] [Google Scholar]
  4. Daniels C. A., LeGoff S. G. Shedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis. Lancet. 1975 Sep 20;2(7934):524–528. doi: 10.1016/s0140-6736(75)90896-x. [DOI] [PubMed] [Google Scholar]
  5. Graham B. J., Minamishima Y., Dresman G. R., Haines H. G., Benyesh-Melnick M. Complement-requiring neutralizing antibodies in hyperimmune sera to human cytomegaloviruses. J Immunol. 1971 Dec;107(6):1618–1630. [PubMed] [Google Scholar]
  6. Grose C., Edmond B. J., Brunell P. A. Complement-enhanced neutralizing antibody response to varicella-zoster virus. J Infect Dis. 1979 Apr;139(4):432–437. doi: 10.1093/infdis/139.4.432. [DOI] [PubMed] [Google Scholar]
  7. Hampar B., Notkins A. L., Mage M., Keehn M. A. Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus. J Immunol. 1968 Mar;100(3):586–593. [PubMed] [Google Scholar]
  8. JOHNSON K. M., BLOOM H. H., MUFSON M. A., CHANOCK R. M. Natural reinfection of adults by respiratory syncytial virus. Possible relation to mild upper respiratory disease. N Engl J Med. 1962 Jul 12;267:68–72. doi: 10.1056/NEJM196207122670204. [DOI] [PubMed] [Google Scholar]
  9. KISCH A. L., JOHNSON K. M. A plaque assay for respiratory syncytial virus. Proc Soc Exp Biol Med. 1963 Mar;112:583–589. doi: 10.3181/00379727-112-28111. [DOI] [PubMed] [Google Scholar]
  10. Kaul A., Scott R., Gallagher M., Scott M., Clement J., Ogra P. L. Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence. Am J Dis Child. 1978 Nov;132(11):1088–1090. doi: 10.1001/archpedi.1978.02120360044006. [DOI] [PubMed] [Google Scholar]
  11. Keller R., Dwyer J. E. Neutralization of poliovirus by IgA coproantibodies. J Immunol. 1968 Aug;101(2):192–202. [PubMed] [Google Scholar]
  12. Majer M. Virus sensitization. Curr Top Microbiol Immunol. 1972;58:69–84. doi: 10.1007/978-3-642-65357-5_2. [DOI] [PubMed] [Google Scholar]
  13. McIntosh K., Masters H. B., Orr I., Chao R. K., Barkin R. M. The immunologic response to infection with respiratory syncytial virus in infants. J Infect Dis. 1978 Jul;138(1):24–32. doi: 10.1093/infdis/138.1.24. [DOI] [PubMed] [Google Scholar]
  14. Mills J., 5th, Van Kirk J. E., Wright P. F., Chanock R. M. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol. 1971 Jul;107(1):123–130. [PubMed] [Google Scholar]
  15. Parrott R. H., Kim H. W., Arrobio J. O., Hodes D. S., Murphy B. R., Brandt C. D., Camargo E., Chanock R. M. Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex. Am J Epidemiol. 1973 Oct;98(4):289–300. doi: 10.1093/oxfordjournals.aje.a121558. [DOI] [PubMed] [Google Scholar]
  16. Takabayashi K., McIntosh K. Effect of heat-labile factors on the neutralization of vaccinia virus by human. Infect Immun. 1973 Oct;8(4):582–589. doi: 10.1128/iai.8.4.582-589.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Welliver R. C., Kaul T. N., Putnam T. I., Sun M., Riddlesberger K., Ogra P. L. The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr. 1980 May;96(5):808–813. doi: 10.1016/s0022-3476(80)80547-6. [DOI] [PubMed] [Google Scholar]
  18. Yoshino K., Taniguchi S. Evaluation of the demonstration of complement-requiring neutralizing antibody as a means for early diagnosis of herpes virus infections. J Immunol. 1966 Feb;96(2):196–203. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES